Antimicrobial Susceptibility Test Market (Product Type - Tests and Kits, Culture Media, Automated Test Systems, Consumables; Method - Broth Dilution Method, Rapid Automated Method, Disk Diffusion Method, Gradient Diffusion Method, Molecular Testing Method; Test Type - Antibacterial, Antifungal, Antiparasitics; Application - Clinical Diagnosis, Drug Discovery and Development; End use - Diagnostic Laboratories and Hospitals, Pharmaceutical and Biotechnology Companies, Research and Academic Institutes, and Contract Research Organizations) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2030

The global antimicrobial susceptibility test market for the historical period 2017–2018 and forecast period 2019–2027, investments in cutting edge research; rising emphasis on remedies for drug and environmental concerns, increasing incidence of infectious diseases and rising antibiotic resistance are projected to drive the global antimicrobial susceptibility test market during the forecast period.

According to the report, the global antimicrobial susceptibility test market was valued at US$ 2,770.9 Mn in 2018 and is anticipated to expand at a CAGR of 4.9% from 2019 to 2027

Increasing Microbial Resistance and Surge in Government Funding to drive the Global market: Key Drivers

Antimicrobial resistance mechanism are emerging and spreading at a global front, which enables the ways to treat common infectious diseases thus results prolonged illness, disability and at times fatal.  Antimicrobial resistance is a complex situation affecting individuals of all ages and races.

According to U.S. Centers for Disease Control and Prevention (CDC) estimated, antibacterial resistance is responsible for over 2 million infections and 23,000 deaths in the U.S. each year and an estimated 25,000 deaths due to antibacterial-resistant infections in Europe. Hence, demand for newer broad spectrum antibacterial drugs is rising. Over 480,000 new cases of multidrug-resistant tuberculosis (MDR-TB) were reported by the WHO in 100 countries in 2013. This increasing microbial resistance is creating a demand for antimicrobial susceptibility tests, contributing to the growth of the global market.

Due to the alarming rise of antibacterial resistance and sparse availability of antibacterial drugs which could cater for the treatment of new infections has been noticed by WHO and other government bodies thus WHO has proposed a new Antibiotic Innovation Funding Mechanism where the government would fund grants and innovation induced prizes which would reward upstream innovation, interim trial results and also the end product results

Governments in several countries are taking initiatives for the allocation of funds needed to create a sustainable and predictable market

Lack of return on investment to Hamper Market

The lack of new, easily identifiable targets, leads to major scientific and technical challenge of new antibacterial drug development increasing the development costs

Discovery and development of antibacterial has become scientifically more complex, expensive, and time consuming over the time, as the new generation antimicrobial has raised the bar and the drug screening process tend to rediscover the same lead compounds over and over again. Drug companies too spend more than $100 million for a phase III program of each antimicrobial drug for a particular indication which would constitute only smaller fraction of the total market

Antimicrobial drugs are taken for a short period of time to cure the patients unlike other drugs which are used to treat chronic illness and are used for the rest of their lives. This makes antibacterial drugs less lucrative business for drug companies. This lack of return on investment hampers the growth of the global market.

 Global Antimicrobial susceptibility test Market: Competitive Landscape

This report profiles major players in the global antimicrobial susceptibility test market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments

The global antimicrobial susceptibility test market is highly fragmented, with the presence of a number of international as well as regional players

Leading players operating in the global antimicrobial susceptibility test market are

• Bio-Rad Laboratories, Inc.
• Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
• Thermo Fisher Scientific, Inc.
• Becton, Dickinson and Company
• Conda
• Creative Diagnostics
• HiMedia Laboratories
• Alifax Holding S.p.A.
• Biotron Healthcare

Global Antimicrobial susceptibility test Market: Key Developments

Key players in the global antimicrobial susceptibility test market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global antimicrobial susceptibility test market. A few expansion strategies adopted by players operating in the global antimicrobial susceptibility test market are:

In December 2017, Beckman Coulter, Inc. announced FDA clearance for its automated Access AMH immunoassay and paramagnetic particle chemiluminescent immunoassay

 The report on the global antimicrobial susceptibility test market discussed individual strategies, followed by company profiles of manufacturers of antimicrobial susceptibility test. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global antimicrobial susceptibility test market.

Key Questions Answered in Global Antimicrobial Susceptibility Test Market Report

• What is the scope of growth of product companies in the global Antimicrobial Susceptibility Test market?
• What will be the Y-o-Y growth of the global Antimicrobial Susceptibility Test market between 2019 and 2027?
• What is the influence of changing trends in technologies on the global Antimicrobial Susceptibility Test market?
• Will North America continue to be the most profitable market for Antimicrobial Susceptibility Test providers?
• Which factors are anticipated to hamper the growth of the global Antimicrobial Susceptibility Test market during the forecast period?
• Which are the leading companies in the global Antimicrobial Susceptibility Test market?

Global Antimicrobial Susceptibility Test Market - Segmentation

Product

• Kits, Reagents & Consumables
• Culture Media
• Automated Test System

Method

• Broth Dilution Method
• Rapid Automated Method
• Disk Diffusion Method
• Gradient Diffusion Method
• Molecular Testing Method

Test Type

• Antibacterial
• Antifungal
• Antiparasitic

Application

• Clinical Diagnosis
• Drug Discovery and Development
• Others

End-user

• Diagnostic Laboratories and Hospitals
• Pharmaceutical and Biotechnology Companies
• Research and Academic Institutes
• Contract Research Organizations

Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Antimicrobial Susceptibility Test Market

4. Market Overview

    4.1. Introduction

        4.1.1. Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Antimicrobial Susceptibility Test Market Analysis and Forecast, 2017–2027

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Market Opportunity Map, by Product Type

    5.2. Porter’s Five Force Analysis

    5.3. Prevalence of Major Infectious Diseases

    5.4. Technological Advancement

    5.5. Advantages and Disadvantages of Methods used for Antimicrobial Susceptibility Testing

6. Global Antimicrobial Susceptibility Test Market Analysis and Forecast, by Product Type

    6.1. Introduction & Definition

        6.1.1. Key Findings / Developments

    6.2. Global Antimicrobial Susceptibility Test Market Value Forecast, by Product Type, 2017–2027

        6.2.1.  Kits, Reagents & Consumables

        6.2.2. Culture Media

        6.2.3. Automated Test System

    6.3. Global Antimicrobial Susceptibility Test Market Attractiveness, by Product Type

7. Global Antimicrobial Susceptibility Test Market Analysis and Forecast, by Method

    7.1. Introduction & Definition

        7.1.1. Key Findings / Developments

    7.2. Global Antimicrobial Susceptibility Test Market Value Forecast, by Method, 2017–2027

        7.2.1. Broth Dilution Method 

        7.2.2. Rapid Automated Method 

        7.2.3. Disk Diffusion Method

        7.2.4. Gradient Diffusion Method

        7.2.5. Molecular Testing Method

    7.3. Global Antimicrobial Susceptibility Test Market Attractiveness, by Method 

8. Global Antimicrobial Susceptibility Test Market Analysis and Forecast, by Test Type

    8.1. Introduction & Definition

        8.1.1. Key Findings / Developments

    8.2. Global Antimicrobial Susceptibility Test Market Value Forecast, by Test Type, 2017–2027

        8.2.1. Antibacterial

        8.2.2. Antifungal

        8.2.3. Antiparasitic

        8.2.4. Others

    8.3. Global Antimicrobial Susceptibility Test Market Attractiveness, by Test Type 

9. Global Antimicrobial Susceptibility Test Market Analysis and Forecast, by Application

    9.1. Introduction & Definition

        9.1.1. Key Findings / Developments

    9.2. Global Antimicrobial Susceptibility Test Market Value Forecast, by Application, 2017–2027

        9.2.1. Clinical Diagnosis

        9.2.2. Drug Discovery and Development

        9.2.3. Others

    9.3. Global Antimicrobial Susceptibility Test Market Attractiveness, by Application 

10. Global Antimicrobial Susceptibility Test Market Analysis and Forecast, by End-user

    10.1. Introduction & Definition

        10.1.1. Key Findings / Developments

    10.2. Global Antimicrobial Susceptibility Test Market Value Forecast, by End-user, 2017–2027

        10.2.1. Diagnostic Laboratories and Hospitals

        10.2.2. Pharmaceutical and Biotechnology Companies

        10.2.3. Research and Academic Institutes

        10.2.4. Contract Research Organizations

    10.3. Global Antimicrobial Susceptibility Test Market Attractiveness, by End-user

11. Global Antimicrobial Susceptibility Test Market Analysis and Forecast, by Region

    11.1. Key Findings

    11.2. Global Antimicrobial Susceptibility Test Market Value Forecast, by Region

        11.2.1. North America 

        11.2.2. Europe 

        11.2.3. Asia Pacific 

        11.2.4. Latin America 

        11.2.5. Middle East & Africa 

    11.3. North America Antimicrobial Susceptibility Test Market Attractiveness, by Region

12. North America Antimicrobial Susceptibility Test Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. North America Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

        12.2.1. Kits, Reagents & Consumables

        12.2.2. Culture Media

        12.2.3. Automated Test System

    12.3. North America Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Method, 2017–2027

        12.3.1. Broth Dilution Method 

        12.3.2. Rapid Automated Method 

        12.3.3. Disk Diffusion Method

        12.3.4. Gradient Diffusion Method

        12.3.5. Molecular Testing Method

    12.4. North America Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

        12.4.1. Antibacterial

        12.4.2. Antifungal

        12.4.3. Antiparasitic

        12.4.4. Others

    12.5. North America Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Application, 2017–2027

        12.5.1. Clinical Diagnosis

        12.5.2. Drug Discovery and Development

        12.5.3. Others

    12.6. North America Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by End-user, 2017–2027

        12.6.1. Diagnostic Laboratories and Hospitals

        12.6.2. Pharmaceutical and Biotechnology Companies

        12.6.3. Research and Academic Institutes

        12.6.4. Contract Research Organizations

    12.7. North America Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Country, 2017–2027

        12.7.1. U.S.

        12.7.2. Canada

    12.8. North America Antimicrobial Susceptibility Test Market Attractiveness Analysis 

        12.8.1. By Product Type

        12.8.2. By Method

        12.8.3. By Test Type

        12.8.4. By Application 

        12.8.5. By End-user

        12.8.6. By Country

13. Europe Antimicrobial Susceptibility Test Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Europe Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

        13.2.1. Kits, Reagents & Consumables

        13.2.2. Culture Media

        13.2.3. Automated Test System

    13.3. Europe Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Method, 2017–2027

        13.3.1. Broth Dilution Method 

        13.3.2. Rapid Automated Method 

        13.3.3. Disk Diffusion Method

        13.3.4. Gradient Diffusion Method

        13.3.5. Molecular Testing Method

    13.4. Europe Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

        13.4.1. Antibacterial

        13.4.2. Antifungal

        13.4.3. Antiparasitic

        13.4.4. Others

    13.5. Europe Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Application, 2017–2027

        13.5.1. Clinical Diagnosis

        13.5.2. Drug Discovery and Development

        13.5.3. Others

    13.6. Europe Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by End-user, 2017–2027

        13.6.1. Diagnostic Laboratories and Hospitals

        13.6.2. Pharmaceutical and Biotechnology Companies

        13.6.3. Research and Academic Institutes

        13.6.4. Contract Research Organizations

    13.7. Europe Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Country, 2017–2027

        13.7.1. U.K.

        13.7.2. Germany

        13.7.3. France

        13.7.4. Italy 

        13.7.5. Spain

        13.7.6. Rest of Europe

    13.8. Europe Antimicrobial Susceptibility Test Market Attractiveness Analysis 

        13.8.1. By Product Type

        13.8.2. By Method

        13.8.3. By Test Type

        13.8.4. By Application 

        13.8.5. By End-user

        13.8.6. By Country

14. Asia Pacific Antimicrobial Susceptibility Test Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Asia Pacific Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

        14.2.1. Kits, Reagents & Consumables

        14.2.2. Culture Media

        14.2.3. Automated Test System

    14.3. Asia Pacific Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Method, 2017–2027

        14.3.1. Broth Dilution Method 

        14.3.2. Rapid Automated Method 

        14.3.3. Disk Diffusion Method

        14.3.4. Gradient Diffusion Method

        14.3.5. Molecular Testing Method

    14.4. Asia Pacific Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

        14.4.1. Antibacterial

        14.4.2. Antifungal

        14.4.3. Antiparasitic

        14.4.4. Others

    14.5. Asia Pacific Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Application, 2017–2027

        14.5.1. Clinical Diagnosis

        14.5.2. Drug Discovery and Development

        14.5.3. Others

    14.6. Asia Pacific Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by End-user, 2017–2027

        14.6.1. Diagnostic Laboratories and Hospitals

        14.6.2. Pharmaceutical and Biotechnology Companies

        14.6.3. Research and Academic Institutes

        14.6.4. Contract Research Organizations

    14.7. Asia Pacific Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Country, 2017–2027

        14.7.1. China

        14.7.2. Japan

        14.7.3. Australia & New Zealand

        14.7.4. India

        14.7.5. Rest of Asia Pacific

    14.8. Asia Pacific Antimicrobial Susceptibility Test Market Attractiveness Analysis 

        14.8.1. By Product Type

        14.8.2. By Method

        14.8.3. By Test Type

        14.8.4. By Application 

        14.8.5. By End-user

        14.8.6. By Country

15. Latin America Antimicrobial Susceptibility Test Market Analysis and Forecast

    15.1. Introduction

        15.1.1. Key Findings

    15.2. Latin America Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

        15.2.1. Kits, Reagents & Consumables

        15.2.2. Culture Media

        15.2.3. Automated Test System

    15.3. Latin America Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Method, 2017–2027

        15.3.1. Broth Dilution Method 

        15.3.2. Rapid Automated Method 

        15.3.3. Disk Diffusion Method

        15.3.4. Gradient Diffusion Method

        15.3.5. Molecular Testing Method

    15.4. Latin America Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

        15.4.1. Antibacterial

        15.4.2. Antifungal

        15.4.3. Antiparasitic

        15.4.4. Others

    15.5. Latin America Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Application, 2017–2027

        15.5.1. Clinical Diagnosis

        15.5.2. Drug Discovery and Development

        15.5.3. Others

    15.6. Latin America Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by End-user, 2017–2027

        15.6.1. Diagnostic Laboratories and Hospitals

        15.6.2. Pharmaceutical and Biotechnology Companies

        15.6.3. Research and Academic Institutes

        15.6.4. Contract Research Organizations

    15.7. Latin America Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Country, 2017–2027

        15.7.1. Brazil

        15.7.2. Mexico

        15.7.3. Rest of Latin America

    15.8. Latin America Antimicrobial Susceptibility Test Market Attractiveness Analysis 

        15.8.1. By Product Type

        15.8.2. By Method

        15.8.3. By Test Type

        15.8.4. By Application 

        15.8.5. By End-user

        15.8.6. By Country

16. Middle East & Africa Antimicrobial Susceptibility Test Market Analysis and Forecast

    16.1. Introduction

        16.1.1. Key Findings

    16.2. Middle East & Africa Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

        16.2.1. Kits, Reagents & Consumables

        16.2.2. Culture Media

        16.2.3. Automated Test System

    16.3. Middle East & Africa Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Method, 2017–2027

        16.3.1. Broth Dilution Method 

        16.3.2. Rapid Automated Method 

        16.3.3. Disk Diffusion Method

        16.3.4. Gradient Diffusion Method

        16.3.5. Molecular Testing Method

    16.4. Middle East & Africa Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

        16.4.1. Antibacterial

        16.4.2. Antifungal

        16.4.3. Antiparasitic

        16.4.4. Others

    16.5. Middle East & Africa Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Application, 2017–2027

        16.5.1. Clinical Diagnosis

        16.5.2. Drug Discovery and Development

        16.5.3. Others

    16.6. Middle East & Africa Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by End-user, 2017–2027

        16.6.1. Diagnostic Laboratories and Hospitals

        16.6.2. Pharmaceutical and Biotechnology Companies

        16.6.3. Research and Academic Institutes

        16.6.4. Contract Research Organizations

    16.7. Middle East & Africa Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Country, 2017–2027

        16.7.1. GCC Countries 

        16.7.2. South Africa

        16.7.3. Israel

        16.7.4. Rest of Middle East & Africa

    16.8. Middle East & Africa Antimicrobial Susceptibility Test Market Attractiveness Analysis 

        16.8.1. By Product Type

        16.8.2. By Method

        16.8.3. By Test Type

        16.8.4. By Application 

        16.8.5. By End-user

        16.8.6. By Country

17. Competition Landscape

    17.1. Market Player - Competition Matrix (by Tier and Size of companies)

    17.2. Market Share / Position Analysis, by Company, 2018

    17.3. Company Profiles

        17.3.1. Bio-Rad Laboratories, Inc.

            17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.1.2. Financial Overview

            17.3.1.3. Product Portfolio

            17.3.1.4. SWOT Analysis

            17.3.1.5. Strategic Overview

        17.3.2. Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)

            17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.2.2. Financial Overview

            17.3.2.3. Product Portfolio

            17.3.2.4. SWOT Analysis

            17.3.2.5. Strategic Overview

        17.3.3. Thermo Fisher Scientific, Inc.

            17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.3.2. Financial Overview

            17.3.3.3. Product Portfolio

            17.3.3.4. SWOT Analysis

            17.3.3.5. Strategic Overview

        17.3.4. Becton, Dickinson and Company

            17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.4.2. Financial Overview

            17.3.4.3. Product Portfolio

            17.3.4.4. SWOT Analysis

            17.3.4.5. Strategic Overview

        17.3.5. Conda

            17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.5.2. Financial Overview

            17.3.5.3. Product Portfolio

            17.3.5.4. SWOT Analysis

            17.3.5.5. Strategic Overview

        17.3.6. Creative Diagnostics

            17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.6.2. Financial Overview

            17.3.6.3. Product Portfolio

            17.3.6.4. SWOT Analysis

            17.3.6.5. Strategic Overview

        17.3.7. HiMedia Laboratories

            17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.7.2. Financial Overview

            17.3.7.3. Product Portfolio

            17.3.7.4. SWOT Analysis

            17.3.7.5. Strategic Overview         

        17.3.8. Alifax Holding S.p.A.

            17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.8.2. Financial Overview

            17.3.8.3. Product Portfolio

            17.3.8.4. SWOT Analysis

            17.3.8.5. Strategic Overview

        17.3.9. Danaher Corporation (Cepheid)

            17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.9.2. Financial Overview

            17.3.9.3. Product Portfolio

            17.3.9.4. SWOT Analysis

            17.3.9.5. Strategic Overview

        17.3.10. Biotron Healthcare 

            17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.10.2. Financial Overview

            17.3.10.3. Product Portfolio

            17.3.10.4. SWOT Analysis

            17.3.10.5. Strategic Overview